https://yaqrit.com/yaqrit-as-part-of-the-aliver-consortium-announces-completion-of-first-randomised-controlled-study-of-dialive-for-aclf-at-easls-digital-international-liver-congress/2025-06-18T20:22:19+01:00https://yaqrit.com/the-aliver-consortium-announces-positive-results-from-phase-2-equivalent-trial-of-the-novel-liver-dialysis-device-dialive/2025-06-18T20:21:18+01:00https://yaqrit.com/the-carbalive-consortium-announces-positive-results-of-a-phase-2-equivalent-trial-of-engineered-macroporous-carbons-as-a-novel-treatment-for-cirrhosis/2025-06-18T20:21:54+01:00https://yaqrit.com/preliminary-results-from-carbalive-and-dialive-trials-signal-potential-for-new-therapies-to-treat-decompensated-cirrhosis-and-reverse-liver-failure/2025-06-18T20:20:35+01:00https://easl.eu/press-release/a-tango-launch-pr/#new_tab2025-06-18T20:20:11+01:00https://www.healio.com/news/hepatology/20210625/novel-liver-dialysis-device-shows-promise-in-treating-liver-failure#new_tab2025-07-02T12:22:48+01:00https://www.newscientist.com/article/2282269-new-form-of-liver-dialysis-could-help-people-with-failed-organ-recover/#new_tab2025-07-02T12:21:52+01:00https://www.youtube.com/watch?v=5aVZe_CJpps#new_tab2025-06-18T16:28:42+01:00https://www.dailymail.co.uk/sciencetech/article-12145915/New-British-designed-dialysis-machine-reverse-liver-disease-rolled-NHS.html2025-07-02T12:19:46+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/06/Journal-of-Hepatology-Randomized-controlled-clinical-trial-of-the-Dialive-liver-dialysis-device.pdf2025-06-30T16:18:40+01:00https://www.independent.co.uk/news/health/nhs-patients-royal-free-hospital-ucl-b2349258.html2025-06-18T16:27:55+01:00https://www.thetimes.co.uk/article/uk-teams-liver-dialysis-machine-could-save-thousands-of-lives-fgq62rk7q2025-07-02T12:14:42+01:00https://www.standard.co.uk/news/health/liver-dialysis-device-safe-treating-liver-failure-b1084876.html2025-07-02T12:17:38+01:00https://www.ucl.ac.uk/news/2024/apr/carbon-beads-help-restore-healthy-gut-microbiome-and-reduce-liver-disease-progression#new_tab2025-06-18T12:41:32+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/05/250110-New-CEO.pdf2025-06-18T16:27:06+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/05/250211-HE-Phase-3.pdf2025-07-02T12:27:53+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/05/EASL-2025-YAQ001.pdf2025-06-30T16:39:24+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/05/EASL-2025-L-OPA-oral.pdf2025-07-04T11:55:13+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/06/20250514-Yaqrit-New-Apts.pdf2025-06-18T16:26:07+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/06/250507-EASL-OPA-PR-Final.pdf2025-06-18T16:33:10+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/06/2025_03_20-Aliver2.0-Grant.pdf2025-07-02T12:25:32+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/06/Gut-A-double-blind-randomised-placebo-controlled-study-to-assess-safety-and-tolerability-of-oral-enterosorbent-YAQ001-in-cirrhotic-patients.pdf2025-06-30T16:12:45+01:00https://gut.bmj.com/content/73/7/11832025-06-30T16:15:49+01:00https://www.nejm.org/doi/full/10.1056/NEJMra19149002025-06-30T16:22:18+01:00https://www.nature.com/articles/nrdp2016412025-06-30T16:23:54+01:00https://www.journal-of-hepatology.eu/article/S0168-8278(23)00351-3/fulltext2025-06-30T16:25:31+01:00https://www.cghjournal.org/article/S1542-3565(22)00462-1/fulltext2025-06-30T16:27:09+01:00https://www.nature.com/articles/s41572-022-00366-62025-06-30T16:28:39+01:00https://www.cghjournal.org/article/S1542-3565(20)31432-4/fulltext2025-06-30T16:30:12+01:00https://www.journal-of-hepatology.eu/article/S0168-8278(22)02939-7/fulltext2025-06-30T16:31:19+01:00https://www.journal-of-hepatology.eu/article/S0168-8278(20)30028-3/abstract#:~:text=Conclusion,in%20patients%20with%20liver%20failure.2025-06-30T16:32:30+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/06/Acute-on-Chronic-Liver-Failure-Is-a-Distinct-Syndrome-That-Develops-in-Patients-With-Acute-Decompensation-of-Cirrhosis.pdf2025-06-30T16:35:41+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/07/Yaqrit-Personnel-Feb-25.pdf2025-07-02T12:33:34+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/07/EASL-2025-YAQ005-Toll-like-receptor-4-inhibition-resotres-cytochrome-C-oxidase.pdf2025-07-07T11:26:37+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/07/EASL-2025-YAQ005-YAQ007-Transcriptomic-and-metabolic-insights-into-hyperammonemia.pdf2025-07-07T11:29:25+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/07/YAQRIT-Summer-Newsletter.pdf2025-07-30T12:48:50+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/11/AASLD-TLM25_Poster_ATANGO_Score_Development.pdf2025-11-10T18:46:17+00:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/11/AASLD-TLM25_Poster_ATANGO_Score_Dynamics_Final.pdf2025-11-10T18:45:39+00:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/11/20251112-YAQ001-FPI.pdf2025-11-12T10:07:49+00:00https://yaqrit.com/_WPY2025/wp-content/uploads/2025/11/YAQRIT-Autumn-Newsletter.pdf2025-12-21T11:23:52+00:00https://youtu.be/3-CgtpgWQtY2025-12-03T16:11:52+00:00https://www.theguardian.com/society/2025/dec/21/nhs-to-trial-potentially-life-saving-treatment-for-deadly-liver-disease?CMP=Share_iOSApp_Other2026-01-14T11:09:16+00:00https://yaqrit.com/_WPY2025/wp-content/uploads/2026/03/YAQRIT-Winter-Newsletter-FINAL.pdf2026-03-16T09:52:05+00:00https://yaqrit.com/_WPY2025/wp-content/uploads/2026/04/20260417-HE-rationale-007-FINAL.pdf2026-04-17T12:30:03+01:00https://yaqrit.com/_WPY2025/wp-content/uploads/2026/07/26-07-13-FPI-YAQ005-A-TANGO.pdf2026-07-13T14:37:24+01:00